Studies have shown that the PI3K/Akt/mTOR signaling pathway is involved in metabolic processes such as glucose uptake and glycolysis, which are closely related to the occurrence and development of breast cancer, indicating that the PI3K/AKT/mTOR pathway should be targeted for the treatment of TNBC [53]. Here, AKT1 is linked to breast carcinoma.